Emcure Pharma to acquire remaining 20.42% stake in Zuventus Healthcare for Rs 724.9 cr

Emcure Pharmaceuticals will acquire the remaining 20.42% stake in Zuventus Healthcare Ltd from minority shareholders for ₹724.9 crore, a move approved by its board. This acquisition, expected to close in the September quarter of FY26, will make Zuventus a wholly-owned subsidiary. Emcure aims to fully consolidate Zuventus financially, driving long-term value creation and unlocking synergies within its domestic business.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fV9J362
via IFTTT